Small Cap Biotech
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Trend Stats
1-Month Return
-4.95%
3-Month Return
+4.23%
12-Month Return
+63.49%
Volatility Score
2.6
RSI
45.9
ST Trend
Down
LT Trend
Up
Short-Term Trend
Down
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Small Cap Biotech
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | $468B | +25.08% | +13.67% | +0.23% | 2.0 | Up | Up |
| AMGN | Amgen | $220B | +53.88% | +16.21% | -8.52% | 2.6 | Neutral | Up |
| GILD | Gilead Sciences | $186B | +38.20% | +20.27% | +2.58% | 2.3 | Up | Up |
| VRTX | Vertex Pharma | $132B | +36.80% | +9.93% | -4.60% | 2.2 | Neutral | Up |
| REGN | Regeneron Pharma | $82B | +44.03% | +27.83% | -3.92% | 2.5 | Neutral | Up |
| MRNA | MODERNA | $78B | +691.63% | +222.44% | +40.27% | 6.0 | Up | Up |
| NTRA | Natera | $59B | +149.78% | +57.25% | +24.74% | 3.0 | Up | Up |
| RVMD | REVOLUTION MEDIC | $43B | +370.15% | +17.72% | -5.54% | 4.1 | Neutral | Up |
| BIIB | Biogen | $33B | +66.85% | +13.41% | +3.78% | 2.5 | Up | Up |
| ALNY | Alnylam Pharma | $33B | -44.48% | -15.12% | +5.75% | 4.1 | Neutral | Down |
| INSM | Insmed | $27B | -10.35% | +17.49% | -1.96% | 4.0 | Neutral | Down |
| ROIV | ROIVANT SCIENCES | $26B | +141.51% | +6.23% | -0.63% | 4.5 | Down | Up |
| INCY | Incyte | $25B | +52.39% | +14.73% | -2.77% | 2.6 | Neutral | Up |
| UTHR | United Therapeut | $20B | +11.00% | -14.13% | -7.93% | 2.9 | Down | Down |
| EXEL | Exelixis | $14B | +49.78% | +9.61% | +6.23% | 2.8 | Up | Up |
| NBIX | Neurocrine Biosc | $14B | -1.38% | -16.33% | -9.21% | 3.0 | Down | Down |
| HALO | Halozyme Therape | $13B | +55.77% | +61.94% | +6.06% | 2.6 | Up | Up |
| SMMT | SUMMIT THERAP | $13B | -19.15% | +14.95% | +28.67% | 6.2 | Up | Down |
| BBIO | BRIDGEBIO PHARMA | $13B | +35.27% | -4.44% | -18.24% | 3.9 | Down | Down |
| TWST | TWIST BIOSCIENCE | $12B | +587.96% | +101.46% | +30.70% | 5.7 | Up | Up |
| BMRN | Biomarin Pharm | $12B | +16.59% | +7.01% | -5.72% | 2.6 | Down | Up |
| MDGL | Madrigal Pharmct | $12B | +21.33% | +0.68% | +0.24% | 3.4 | Down | Neutral |
| KRYS | KRYSTAL BIOTECH | $10B | +114.06% | -0.77% | +0.95% | 3.2 | Neutral | Up |
| KYMR | KYMERA THERAP | $9.6B | +115.52% | +15.96% | -4.33% | 4.3 | Neutral | Up |
| ARWR | Arrowhead Phrmct | $9.3B | +108.69% | -17.22% | -23.82% | 6.1 | Down | Down |
| IBRX | IMMUNITYBIO | $9.2B | +251.22% | +10.77% | +13.98% | 5.8 | Up | Up |
| CYTK | Cytokinetics | $9.1B | +37.28% | -19.14% | -14.83% | 4.0 | Down | Down |
| PTGX | Protagonist Ther | $8.9B | +112.27% | +12.44% | -11.23% | 3.9 | Down | Up |
| TGTX | TG Therap | $8.8B | +66.05% | +7.31% | +2.70% | 4.0 | Up | Up |
| PCVX | VAXCYTE | $8.5B | +77.04% | +5.62% | -8.03% | 3.9 | Down | Up |
| PRAX | PRAXIS PRECIS | $7.9B | +472.16% | -8.79% | -23.43% | 5.4 | Down | Down |
| SYRE | Spyre Therap | $7.7B | +457.91% | +0.99% | -18.34% | 5.4 | Down | Up |
| IONS | Ionis Pharmaceut | $7.3B | -30.43% | -42.75% | -29.38% | 5.3 | Down | Down |
| IMVT | IMMUNOVANT | $7B | +116.98% | -11.04% | -21.51% | 4.6 | Down | Up |
| ALKS | Alkermes | $6.8B | +50.35% | -19.15% | -16.53% | 3.7 | Down | Up |
| RYTM | RHYTHM PHARM | $6.8B | -0.84% | -8.59% | -11.78% | 4.1 | Down | Down |
| CGON | CG ONCOLOGY | $6.1B | +88.49% | +0.06% | -12.11% | 4.7 | Down | Up |
| SRRK | SCHOLAR RCK HLDG | $5.9B | +40.94% | -7.11% | -16.48% | 5.6 | Down | Neutral |
| MIRM | MIRUM REG S-AI | $5.8B | +21.46% | -22.28% | -7.61% | 4.2 | Down | Down |
| TVTX | TRAVERE THERAPET | $5.7B | +146.37% | +5.08% | -7.05% | 4.0 | Down | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |